http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102872238-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0e72f3008c51bccd2180b22758cb1ae
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-752
filingDate 2012-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d51be6838558e8addac9638bd0e24ca
publicationDate 2014-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-102872238-B
titleOfInvention Medicine for treating osteoarthrosis and preparation method thereof
abstract The invention belongs to an external medicine, in particular to a medicine for treating osteoarthrosis, which is prepared from the following raw materials by weight: 20 to 80 parts of caulis spatholobi, 5 to 30 parts of flos carthami, 10 to 40 parts of radix angelicae pubescentis, 5 to 30 parts of radix aconiti preparata, 15 to 40 part of rhizoma drynariae, 10 to 50 parts of radix achyranthis bidentatae, 10 to 30 parts of pericarpium citri reticulatae viride and 10 to 30 parts of spina gleditsiae; and according to the conventional process, the medicine is added or not added with the conventional adjuvants to prepare into external powder, a paste, an emulsifier or a cataplasm. The medicine provided by the invention has the effects on removing blood stasis, expelling cold and dehumidifying, dredging the channels and collaterals to relieve pain and tonifying kidney and strengthening bones, so that the external medicine is utilized to treat osteoproliferation, cervical spondylosis, lumbar spondylosis, lumbar disc herniation, scapulohumeral periarthritis, lumbocrural pain and spur etc., and extensively treat femoral head necrosis, rheumatism and rheumatoid and the like; and the external medicine has the advantages of being convenient to use, quick to relieve the pain, definite in efficacy, low in cost, high in cure rate, free from side effects and being capable of4 directly focusing the efficacy on the affected parts and the like.
priorityDate 2012-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101579484-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559192
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4068533
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451221555
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 27.